{"id":26652,"date":"2019-10-18T12:36:59","date_gmt":"2019-10-18T12:36:59","guid":{"rendered":"http:\/\/confederacionssc.es\/?p=26652"},"modified":"2022-06-29T10:44:23","modified_gmt":"2022-06-29T10:44:23","slug":"aval-cientifico-de-sefifac-a-la-i-jornada-de-investigacion-de-fibromialgia-em-sfc-sqm-y-ehs-creacion-red-nacional-de-investigacion","status":"publish","type":"post","link":"https:\/\/confesq.org\/?p=26652","title":{"rendered":"AVAL CIENT\u00cdFICO DE SEFIFAC A LA I \u00abJORNADA DE INVESTIGACI\u00d3N DE FIBROMIALGIA, EM\/SFC, SQM Y EHS. CREACI\u00d3N RED NACIONAL DE INVESTIGACI\u00d3N\u00bb"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text css=\u00bb.vc_custom_1571401134145{margin-right: 30px !important;margin-left: 30px !important;}\u00bb]<\/p>\n

AVAL CIENT\u00cdFICO DE SEFIFAC A LA I \u00abJORNADA DE INVESTIGACI\u00d3N DE FIBROMIALGIA, EM\/SFC, SQM Y EHS. CREACI\u00d3N RED NACIONAL DE INVESTIGACI\u00d3N\u00bb<\/h4>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_single_image image=\u00bb26638″ img_size=\u00bbfull\u00bb alignment=\u00bbcenter\u00bb][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00bb.vc_custom_1571401708690{margin-right: 30px !important;margin-left: 30px !important;}\u00bb]<\/p>\n

La Sociedad Espa\u00f1ola de Fibromialgia y S\u00edndrome de Fatiga Cr\u00f3nica, SEFIFAC<\/a>, con fecha 17 de octubre de 2019, ha certificado la Jornanda \u00ab\u00daltimos avances en la investigaci\u00f3n de Fibromialgia, SFC\/EM, SQM y EHS. Creaci\u00f3n de una Red Nacional de Investigaci\u00f3n\u00bb que organizamos y que se celebrar\u00e1 el pr\u00f3ximo 25 de octubre en el Centro de Investigaci\u00f3n Pr\u00edncipe Felipe de Valencia (CIPF) una vez valorada la documentaci\u00f3n recibida. Con este aval, SEFIFAC<\/a> reconoce el inter\u00e9s cient\u00edfico del contenido de dichas Jornadas.<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00bb.vc_custom_1571401748957{margin-right: 30px !important;margin-left: 30px !important;}\u00bb]<\/p>\n

Este es el programa definitivo de la Jornada:<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text css=\u00bb.vc_custom_1571659768890{margin-right: 30px !important;margin-left: 30px !important;}\u00bb]<\/p>\n

\n
PROGRAMA<\/strong><\/div>\n
<\/div>\n
PRIMERA PARTE: Actualizaci\u00f3n en la Investigaci\u00f3n<\/span><\/div>\n
Dirigida a:\u00a0 Profesionales y Equipos Directivos de asociaciones de pacientes<\/em><\/div>\n
9:30 h. Recogida de Acreditaciones<\/strong><\/div>\n
10:00 h. Inaguraci\u00f3n\u00a0<\/strong><\/div>\n
\n
    \n
  • Dra. Mercedes Hurtado. Presidenta del Colegio de M\u00e9dicos de Valencia.<\/li>\n
  • Dra. Deborah J. Burks. Directora del CIPF.<\/li>\n
  • D. Vicente de Juan. Director Econ\u00f3mico del Instituto de Investigaci\u00f3n Sanitaria- INCLIVA.<\/li>\n
  • D\u00f1a. M\u00aa Jos\u00e9 F\u00e9lix. Presidenta de CONFESQ.<\/li>\n<\/ul>\n<\/div>\n
    10:15 h. Ponencia: Fibromialgia<\/strong><\/div>\n
    \n
      \n
    • Dr. Antonio Collado. Reumat\u00f3logo del Hospital Cl\u00ednic de Barcelona. Presidente de SEFIFAC, Barcelona, Espa\u00f1a.<\/li>\n
    • Dr. Juan Manuel Falc\u00f3n. Bi\u00f3logo Molecular en CIC bioGUNE, Vizcaya, Espa\u00f1a.<\/li>\n<\/ul>\n<\/div>\n
      11:00 h. Caf\u00e9 Relacional y P\u00f3sters<\/strong><\/div>\n
      11:30 h. Mesa redonda: Sensibilidad Qu\u00edmica M\u00faltiple y Electrohipersensibilidad<\/strong><\/div>\n
      \n
        \n
      • Modera: Dr. Ceferino Maestu. Centro de Tecnolog\u00eda Biom\u00e9dica (CTB), Universidad Polit\u00e9cnica de Madrid. Presidente de la SESSEC, Espa\u00f1a.<\/li>\n
      • Dra. Pilar Mu\u00f1oz Calero. Presidenta de la Fundaci\u00f3n Blue-Alborada. Directora M\u00e9dica de Blue Healthcare, Madrid, Espa\u00f1a.<\/li>\n
      • Dr. Antonio M\u00aa Pasciuto. Presidente de la Associazione Italiana Ambiente e Medicina della Salute- ASSISMAS. Miembro del Consejo Directivo de la Accademia Europea di Medicina Ambientale- EUROPAEM, Italia.<\/li>\n<\/ul>\n<\/div>\n
        12:45 h. Ponencia: S\u00edndrome de Fatiga Cr\u00f3nica\/ Encefalomielitis Mi\u00e1lgica<\/strong><\/div>\n
        \n
          \n
        • Dr. Jos\u00e9 Alegre. Unidad de S\u00edndromes de Sensibilidad Central del Hospital Vall d\u00b4Hebron, Barcelona, Espa\u00f1a.<\/li>\n
        • Dr. Pawe\u0142 Zalewski. Departamento de Higiene, Epidemiolog\u00eda y Ergonom\u00eda en Uniwersytet Mikolaja Kopernika Collegium Medicum, Bydgoszcz, Polonia.<\/li>\n<\/ul>\n

          14:15 Clausura:<\/strong><\/p>\n

            \n
          • D\u00f1a. Isaura Navarro. Secretaria Auton\u00f3mica de Salud P\u00fablica y Sistema Sanitario P\u00fablico de la Comunidad Valenciana, Espa\u00f1a.<\/li>\n<\/ul>\n<\/div>\n
            SEGUNDA PARTE: Promoci\u00f3n de Redes de Investigaci\u00f3n Espa\u00f1olas<\/span><\/div>\n
            Dirigida solo a profesionales\u00a0<\/em><\/div>\n
            16:00 h. Ponencia: Redes de Investigaci\u00f3n<\/strong><\/div>\n
            \n
              \n
            • Dr. Juan Manuel Falc\u00f3n. Bi\u00f3logo Molecular en CIC bioGUNE, Vizcaya, Espa\u00f1a.<\/li>\n<\/ul>\n<\/div>\n
              17:00 h. Grupos de Trabajo<\/strong><\/div>\n
                \n
              • \n
                A) Fibromialgia<\/div>\n<\/li>\n
              • \n
                B) S\u00edndrome de Fatiga Cr\u00f3nica\/ Encefalomielitis Mi\u00e1lgica<\/div>\n<\/li>\n
              • \n
                C) Sensibilidad Qu\u00edmica M\u00faltiple+Electrohipersensibilidad<\/div>\n<\/li>\n<\/ul>\n<\/blockquote>\n

                [\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_single_image image=\u00bb26578″ img_size=\u00bbfull\u00bb alignment=\u00bbcenter\u00bb][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

                [vc_row][vc_column][vc_column_text css=\u00bb.vc_custom_1571401134145{margin-right: 30px !important;margin-left: 30px !important;}\u00bb] AVAL CIENT\u00cdFICO DE SEFIFAC A LA I \u00abJORNADA DE INVESTIGACI\u00d3N DE FIBROMIALGIA, EM\/SFC, SQM…<\/p>\n","protected":false},"author":2,"featured_media":26638,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"aside","meta":{"footnotes":""},"categories":[105],"tags":[131],"class_list":{"0":"post-26652","1":"post","2":"type-post","3":"status-publish","4":"format-aside","5":"has-post-thumbnail","7":"category-novedades","8":"tag-jornadas-fm-sfc-em-sqm-ehs","9":"post_format-post-format-aside"},"menu_order":0,"_links":{"self":[{"href":"https:\/\/confesq.org\/index.php?rest_route=\/wp\/v2\/posts\/26652","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/confesq.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/confesq.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/confesq.org\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/confesq.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=26652"}],"version-history":[{"count":7,"href":"https:\/\/confesq.org\/index.php?rest_route=\/wp\/v2\/posts\/26652\/revisions"}],"predecessor-version":[{"id":28279,"href":"https:\/\/confesq.org\/index.php?rest_route=\/wp\/v2\/posts\/26652\/revisions\/28279"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/confesq.org\/index.php?rest_route=\/wp\/v2\/media\/26638"}],"wp:attachment":[{"href":"https:\/\/confesq.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=26652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/confesq.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=26652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/confesq.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=26652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}